TMCnet News
Big Data to Transform Healthcare and Pharma Commercial Strategy - The Views of Major Organizations Within the Industry on Big Data, and Assess Real-World Case Studies - Research and MarketsDUBLIN, Jan 19, 2017 /PRNewswire/ -- Research and Markets has announced the addition of the "Big Data: Embracing Data to Transform Healthcare and Pharma Commercial Strategy - Featuring Expert Panel Views from Industry Survey 2016" report to their offering. Our latest report,"" Big Data: Embracing Data to Transform Healthcare and Pharma Commercial Strategy Featuring Expert Panel Views from Industry Survey 2016"" provides a comprehensive analysis of the Big Data landscape. We conducted extensive research in order to provide a comprehensive view of Big Data for healthcare landscape. This new report adds to our unique portfolio of trusted industry analyses that enable our clients to assess the most promising areas in the market and exploit key business opportunities. This report will allow you to: - Gain insightful analyses and comprehensive understanding of Big Data in healthcare - Understand the key drivers necessitating the use of Big Data and the main barriers to implementation - Understand the views of 73 organizations within the industry on Big Data, and assess real-world case studies - Assess the most relevant uses of Big Data within your company, and effective ways of implementing Big Data strategies Key Topics Covered: 1 Tables & Figures 2 Big Data Overview 3 Drivers of Big Data in Healthcare 4 Commercial Implications of Big Data in Healthcare 5 Challenges Associated with Big Data in Healthcare 6 Big Data in Practice: Real-World Case Studies and Technical Details 7 Strategic Considerations for Effective Implementation of Big Data in Healthcare 8 Appendix Companies Mentioned - Allergan - AstraZeneca - Medtronic - Novartis - Novo Nordisk - Pfizer - Roche - Sanofi - Teva For more information about this report visit http://www.researchandmarkets.com/research/8lwwrd/big_data Media Contact: Research and Markets |